Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.

Last updated on 19-1-2023 by Cindy Simoens

Peer reviewed scientific article

Engels

SCIENSANO

Samenvatting:

BACKGROUND: Persistent infection with high-risk human papillomaviruses (hrHPV) types is causally linked with the development of cervical precancer and cancer. HPV types 16 and 18 cause approximately 70% of cervical cancers worldwide. OBJECTIVES: To evaluate the harms and protection of prophylactic human papillomaviruses (HPV) vaccines against cervical precancer and HPV16/18 infection in adolescent girls and women. SEARCH METHODS: We searched MEDLINE, Cochrane Central Register of Controlled Trials (CENTRAL) and Embase (June 2017) for reports on effects from trials. We searched trial re…

Associated health topics:

QR code

QR code for this page URL